Partial A1 Adenosine Receptor Agonists from a Molecular Perspective and Their Potential Use as Chronic Ventricular Rate Control Agents During Atrial Fibrillation (AF)

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 8, 2004-04 ,pp. : 839-854

Bentham Science Publishers

Access to resources Recommend Favorite

Dronedarone improves ventricular rate control among patients with atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-03 ,pp. : 1011-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation during Cardioversion in Patients with Atrial Fibrillation: Current Clinical Practice

By Stellbrink Christoph   Schimpf Thomas  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 3, 2005-01 ,pp. : 155-162

Adis International

Access to resources Recommend Favorite

Exercise Heart Rate Acceleration Patterns during Atrial Fibrillation and Sinus Rhythm

By Buber Jonathan   Glikson Michael   Eldar Michael   Luria David  

Annals of Noninvasive Electrocardiology, Vol. 16, Iss. 4, 2011-10 ,pp. : 357-364

Blackwell Publishing

Access to resources Recommend Favorite